美东时间2020年5月15日,AYLA股价今开15.2400美元,盘中最高15.2400美元,盘中最低14.9500美元,股价收涨0.27%,涨0.0400点,报15.0400美元

Ayala pharmaceuticals(AYLA.US)美股上市收涨!罕见病适应症推动产品加速审批

美国时间5月8日,AyalaPharmaceuticals(AYLA.US)在纳斯达克上市。本次上市Ayala发行价为15美元,位于发行价格区间的中位,共计发行333.3万股。周五开盘,Ayala开盘价为15.66美元,随后迅速上涨又逐步回落,最终股价停留在15.03美元。...网页链接

AYLA简介

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company founded in November 2017 after acquiring an exclusive, worldwide license to its product candidates AL101 and AL102 from Bristol-Myers Squibb (BMS). It is focused on developing and commercializing small molecule therapeutics for patients living with rare and aggressive cancers, especially in genetically defined patient populations.